Breast Neoplasms (radionuclide imaging) < Breast Neoplasms (radiotherapy) < Breast Neoplasms (secondary)

Facettes :

List of bibliographic references indexed by Breast Neoplasms (radiotherapy)

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]

Ident.	Authors (with country if any)	Title
000923 (2012)		¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
000F75 (2012)		Block copolymer micelles target Auger electron radiotherapy to the nucleus of HER2-positive breast cancer cells.
000F77 (2012)		Biotinylated polyacrylamide-based metal-chelating polymers and their influence on antigen recognition following conjugation to a trastuzumab Fab fragment.
001000 (2012)		Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
001863 (2010)		Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy.
001874 (2010)		Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.
001B14 (2010)		Antitumor effects and normal-tissue toxicity of 111In-nuclear localization sequence-trastuzumab in athymic mice bearing HER-positive human breast cancer xenografts.
002286 (2008)		Increased activity on In-111 octreotide imaging due to radiation fibrosis.
002653 (2007)		Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer.
002841 (2007)		(111)In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer.
002C07 (2005)		Splenic volume change and nodal tumor response in non-Hodgkin's lymphoma patients after radioimmunotherapy using radiolabeled Lym-1 antibody.
002C52 (2005)		Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry.
002D63 (2005)		High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human anti-mouse antibody.
002F68 (2004)		Preclinical characterisation of 111In-DTPA-trastuzumab.
003085 (2004)		Evaluation of a cathepsin-cleavable peptide linked radioimmunoconjugate of a panadenocarcinoma MAb, m170, in mice and patients.
003415 (2003)		"Trojan horse" strategy enters phase 1 trial for breast cancer.
003850 (2001)		Amplified delivery of indium-111 to EGFR-positive human breast cancer cells.
003954 (2000)		OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy.
003960 (2000)		Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy.
003A93 (2000)		111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
003D75 (1998)		Somatostatin receptors and breast cancer.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Breast Neoplasms (radiotherapy)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Breast Neoplasms (radiotherapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Breast Neoplasms (radiotherapy)
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024